Detection of eight frequently encountered point mutations in mitochondria in Chinese patients suggestive of mitochondrial encephalomyopathies

Mitochondrion
Yanyan CaoYu Qi

Abstract

To evaluate eight frequently encountered mitochondrial DNA (mtDNA) point mutations (A3243G, T8993G/C, A8344G, A1555G, G11778A, G3460A and T14484C) in Chinese, we recruited 1559 sporadic patients suspected of mitochondrial diseases and 206 family members. In suspected patients, 158 cases were detected with one of these eight mtDNA mutations (10.1%). A3243G was the most common mtDNA mutation both in suspected patients (9.4%) and in the relatives (34.2%). In addition, the ratios of A3243G (mutant/wild-type) and A8344G were significantly correlated with the patients' age of examination. Moreover, in 76 unrelated probands, the ratio of A3243G was correlated well with their seizures and myopathies.

References

Feb 21, 1998·Nucleic Acids Research·A M KogelnikD C Wallace
Nov 22, 2000·American Journal of Human Genetics·S RahmanA Suomalainen
Jun 14, 2003·Brain : a Journal of Neurology·Daniela SkladalDavid R Thorburn
Jan 30, 2004·Internal Medicine Journal·R MarottaS Collins
Dec 4, 2004·Biochimica Et Biophysica Acta·Andrew M SchaeferPatrick F Chinnery
Nov 30, 2006·Neurology·E MoravaJ A M Smeitink
Feb 16, 2007·Mitochondrion·Neil ManwaringCarolyn M Sue
Sep 22, 2007·Annals of Neurology·Andrew M SchaeferDouglass M Turnbull
Jan 6, 2009·Acta Paediatrica·S WolnyT Cheetham
Mar 3, 2009·American Journal of Medical Genetics. Part a·Mahsa MehrazinSalvatore DiMauro
Apr 22, 2009·Pediatric Neurology·Luísa DiogoCatarina Resende Oliveira
May 23, 2009·Mitochondrion·Yinan MaYu Qi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.